Fibroblast Growth Factor 23 in Multiple Myeloma Patients with Renal Impairment

被引：0
|
作者：
Ibrahim, Nahed Moawad [1 ]
El Afifi, Amal Mostafa [1 ]
Abdelallim, Nada Shawky Rizk [1 ]
Abdullah, Nour El Hoda Hussein [1 ]
机构：
[1] Ain Shams Univ, Clin Hematol & Bone Marrow Transplantat Unit, Fac Med, Cairo, Egypt
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
MM; fibroblast growth factor 23; newly diagnosed multiple myeloma; renal impairment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-299
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [41] Fibroblast Growth Factor-23 importance as a prognostic factor in hemodialysis patients
    Al Atbee, Mohammed Younus Naji
    Hamu, Ali Hussein
    Hammoudi, Faten Abdulghani
    Allawi, Ali Abdulmajid Dyab
    Tuama, Hala Sami
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2023, 18 (09): : 423 - 431
  • [42] Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study
    Mehta, Rupal
    Cai, Xuan
    Hodakowski, Alexander
    Lee, Jungwha
    Leonard, Mary
    Ricardo, Ana
    Chen, Jing
    Hamm, Lee
    Sondheimer, James
    Dobre, Mirela
    David, Valentin
    Yang, Wei
    Go, Alan
    Kusek, John W.
    Feldman, Harold
    Wolf, Myles
    Isakova, Tamara
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (11): : 1795 - 1803
  • [43] Fibroblast growth factor 23 and renal function among young and healthy individuals
    Bernasconi, Raffaele
    Aeschbacher, Stefanie
    Blum, Steffen
    Mongiat, Michel
    Girod, Marc
    Todd, John
    Estis, Joel
    Nolan, Niamh
    Renz, Harald
    Risch, Lorenz
    Conen, David
    Risch, Martin
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (09) : 1483 - 1489
  • [44] Fibroblast Growth Factor 23 in Children With End Stage Renal Disease on Hemodialysis
    Mohamed, Ensaf K.
    Al-Saeed, Amany
    Ahmed, Basma K.
    Schaalan, Mona F.
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2012, 9 (02): : 1122 - 1127
  • [45] Fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma.
    Paterson, JL
    Li, ZH
    Bali, M
    Trieu, Y
    Pollett, J
    Stewart, AK
    BLOOD, 2001, 98 (11) : 773A - 773A
  • [46] Fibroblast Growth Factor 23 and Placental Growth Factor in Patients with Psoriasis and their Relation to Disease Severity
    Okan, Gokhan
    Baki, Adile Merve
    Yorulmaz, Eda
    Dogru-Abbasoglu, Semra
    Vural, Pervin
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2016, 46 (02): : 174 - 179
  • [47] Autologous stem cell transplantation in multiple myeloma patients with renal impairment
    Zhai, Yingying
    Yan, Lingzhi
    Jin, Song
    Yan, Shuang
    Yao, Weiqin
    Shang, Jingjing
    Shi, Xiaolan
    Wang, Ruju
    Kang, Huizhu
    Lu, Jing
    Zhu, Ziling
    Tang, Fang
    Wei, Feng
    Fu, Chengcheng
    Wu, Depei
    ANNALS OF HEMATOLOGY, 2023, 102 (03) : 621 - 628
  • [48] A Report of 134 Newly Diagnosed Multiple Myeloma Patients with Renal Impairment
    Liu, Aijun
    Yang, Guangzhong
    Geng, Chuanying
    Wang, Huijuan
    Li, Lihong
    Li, Yanchen
    Wu, Yin
    Tian, Ying
    Leng, Yun
    Wang, Guorong
    Gao, Wen
    Chen, Wenming
    ACTA HAEMATOLOGICA, 2016, 135 (03) : 140 - 145
  • [49] Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment
    Chanan-Khan, Asher A.
    San Miguel, Jesus F.
    Jagannath, Sundar
    Ludwig, Heinz
    Dimopoulos, Meletios A.
    CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2145 - 2163
  • [50] HEALTHCARE RESOURCE UTILIZATION AND COSTS OF RENAL IMPAIRMENT IN PATIENTS WITH MULTIPLE MYELOMA
    Bhowmik, D.
    Song, X.
    Intorcia, M.
    Kent, S. T.
    Shi, N.
    VALUE IN HEALTH, 2017, 20 (05) : A358 - A358
12345